Online inquiry

IVTScrip™ mRNA-Human Alkaline phosphatase, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK21422MR)

This product GTTS-WK21422MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the Alkaline phosphatase protein. This product can be used in Pluripotent stem cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_031313.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 251
UniProt ID P10696
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human Alkaline phosphatase, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK21422MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK8885MR IVTScrip™ mRNA-Human ADAD1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADAD1
GTTS-WK22768MR IVTScrip™ mRNA-Human ATM, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ATM
GTTS-WK20492MR IVTScrip™ mRNA-Human Aldehyde Dehydrogenase 1-A1, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA Aldehyde Dehydrogenase 1-A1
GTTS-WK18451MR IVTScrip™ mRNA-Human AMHR2, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AMHR2
GTTS-WK9066MR IVTScrip™ mRNA-Human ABHD17A, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ABHD17A
GTTS-WK15081MR IVTScrip™ mRNA-Human AKT2, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA AKT2
GTTS-WK18682MR IVTScrip™ mRNA-Human AKT3, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA AKT3
GTTS-WK8460MR IVTScrip™ mRNA-Human ABHD12, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ABHD12
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW